Japan team uncovers thalidomide mystery

March 12, 2010

Japanese scientists have uncovered how thalidomide led to deformities in children born to mothers taking the drug in the 1950s and 1960s, according to a study released Friday.

The researchers at the Tokyo Institute of Technology have now unlocked the mechanism by which -- an anti-nausea drug given to that turned into one of the worst pharmaceutical disasters in history -- triggered the deformities in developing fetuses.

"Though scientists have proposed a number of hypotheses, the drug's mechanism of action has been a mystery until now," the researchers said.

In the study published in the March 12 issue of the journal Science, the researchers concluded that thalidomide causes deformities in developing limbs by inhibiting production of a protein called cereblon, which in turn produces enzymes needed for limb development.

The study, which used chick and zebrafish embryos, may lead to the development of safer alternatives for thalidomide, which is now being used for treatments of some cancers and for , the researchers said.

Thalidomide was launched in October 1957 and was sold in nearly 50 countries before being withdrawn little more than four years later after babies began showing the severe side effects of the drug.

Thalidomide, when taken by pregnant women, stunted the growth of fetal arms and legs, and also put the at risk of ear and eye defects, and various other internal defects, including those of the heart, kidneys and digestive tract.

Around 10,000 children around the world were born with deformities, such as the absence of arms and legs, as a result of thalidomide.

Related Stories

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

physpuppy
5 / 5 (1) Mar 12, 2010
For background in this topic, the article in Wilkipedia is interesting:
http://en.wikiped...lidomide

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.